GSK plc GSK recently announced that EMA has accepted the regulatory filing seeking approval for its IL-5 inhibitor ...

Weber said it is the right time to appoint a successor given "our competitive growth outlook, new product launches expected ...

The Mooroopna Water Tower will be one of the landmarks lighting up for Feeding Tube Awareness Week. Landmarks in Shepparton and Mooroopna will be lit up in purple and blue for Feeding Tube Awareness ...

Celldex Therapeutics , Inc. (NASDAQ:CLDX), with a market capitalization of $1.72 billion, is a biopharmaceutical company focused on developing innovative therapies for challenging diseases, with its ...

ALLERGIC rhinitis (AR) is a prevalent upper airway condition caused by an IgE-mediated type 1 hypersensitivity reaction to ...

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.